Peripubertal Diazepam Administration Prevents the Emergence of Dopamine System Hyperresponsivity in the MAM Developmental Disruption Model of Schizophrenia

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neuropsychopharmacology

• Publication date

  2013-04-23

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1038/npp.2013.101PMID 23612434PMCID PMC3746684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• First-Episode Psychosis: An Inflammatory State?

  2014cited by this paper
• HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia.

  2012cited by this paper
• Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 years.

  2012cited by this paper
• Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats.

  2012cited by this paper
• Stress and the prodromal phase of psychosis.

  2012cited by this paper
• Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis

  2012cited by this paper
• Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.

  2012cited by this paper
• Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons.

  2012cited by this paper
• Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.

  2011cited by this paper
• Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.

  2011cited by this paper
• A Novel α5GABAAR-Positive Allosteric Modulator Reverses Hyperactivation of the Dopamine System in the MAM Model of Schizophrenia

  2011cited by this paper
• Pituitary volume, stress reactivity and genetic risk for psychotic disorder

  2011cited by this paper
• Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.

  2011cited by this paper
• Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth.

  2010cited by this paper
• Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis.

  2010cited by this paper
• Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis.

  2010cited by this paper
• Use of food wafers for multiple daily oral treatments in young rats.

  2009cited by this paper
• A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia

  2009cited by this paper
• Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.

  2009cited by this paper
• Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia.

  2009cited by this paper
• Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia.

  2008cited by this paper
• Stress and psychosis: towards the development of new models of investigation.

  2007cited by this paper
• Aberrant Hippocampal Activity Underlies the Dopamine Dysregulation in an Animal Model of Schizophrenia

  2007influential reference
• Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.

  2007cited by this paper
• Hypothalamic abnormalities in schizophrenia: sex effects and genetic vulnerability.

  2007cited by this paper
• Schizophrenia genes - famine to feast.

  2006cited by this paper
• Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development.

  2006cited by this paper
• Decrease in parvalbumin‐expressing neurons in the hippocampus and increased phencyclidine‐induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia

  2006cited by this paper
• A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.

  2006cited by this paper
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  2005cited by this paper
• Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis.

  2005cited by this paper
• Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States

  2005cited by this paper
• Pathogenesis of schizophrenia: a psychopathological perspective

  2005cited by this paper
• Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms.

  2004cited by this paper
• Disruption of Neurogenesis on Gestational Day 17 in the Rat Causes Behavioral Changes Relevant to Positive and Negative Schizophrenia Symptoms and Alters Amphetamine-Induced Dopamine Release in Nucleus Accumbens

  2004cited by this paper
• The stress cascade and schizophrenia: etiology and onset.

  2003cited by this paper
• Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia.

  2003cited by this paper
• Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.

  2003cited by this paper
• Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

  2003cited by this paper
• A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia.

  2002cited by this paper
• Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia.

  2002cited by this paper
• Amygdalar activation alters the hippocampal GABA system: “Partial” modelling for postmortem changes in schizophrenia

  2001cited by this paper
• Dopamine Attenuates Prefrontal Cortical Suppression of Sensory Inputs to the Basolateral Amygdala of Rats

  2001cited by this paper
• Probing the human hippocampus using rCBF: Contrasts in schizophrenia

  2001cited by this paper
• Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia.

  2001cited by this paper
• Increased dopamine transmission in schizophrenia: relationship to illness phases.

  1999cited by this paper
• SPECT study of visual fixation in schizophrenia and comparison subjects.

  1999cited by this paper
• Evidence for altered trisynaptic circuitry in schizophrenic hippocampus.

  1999cited by this paper
• Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy.

  1999cited by this paper
• Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study.

  1998cited by this paper
• Cortisol levels during human aging predict hippocampal atrophy and memory deficits

  1998cited by this paper
• Cortisol levels during human aging predict hippocampal atrophy and memory deficits

  1998cited by this paper
• The modulation of corticoaccumbens transmission by limbic afferents and dopamine: a model for the pathophysiology of schizophrenia.

  1998cited by this paper
• Schizophrenia: a neural diathesis-stress model.

  1997cited by this paper
• Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors.

  1995cited by this paper
• Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

  1983cited by this paper

• The ventral/anterior hippocampus as a central hub for stress-related dopaminergic circuit dysfunction in psychiatric disorders.

  2026cites this paper
• GABA Dysfunction in Schizophrenia: The GABAA Receptor as a Potential Therapeutic Target

  2025cites this paper
• Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis

  2025cites this paper
• Intrinsic metabolic and immune impairments in a genetic mouse model of schizophrenia

  2025cites this paper
• Cannabidiol attenuates behavioral and electrophysiological changes in the MAM model of schizophrenia in male and female rats.

  2025cites this paper
• Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review

  2025cites this paper
• Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis

  2024cites this paper
• Abnormalities in behavior relevant to schizophrenia in embryonic day 17 MAM-exposed rodent models: A systematic review and meta-analysis.

  2024cites this paper
• Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for Psychosis

  2024cites this paper
• The antipsychotic agent sulpiride microinjected into the ventral pallidum restores positive symptom-like habituation disturbance in MAM-E17 schizophrenia model rats

  2024cites this paper
• Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis

  2024cites this paper
• The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.

  2024cites this paper
• Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis

  2024cites this paper
• Aberrant Hippocampal Development in Early-onset Mental Disorders and Promising Interventions: Evidence from a Translational Study

  2023cites this paper
• Sex-dependent emergence of prepubertal social dysfunction and augmented dopamine activity in a neurodevelopmental rodent model relevant for schizophrenia.

  2023cites this paper
• Update on current animal models for schizophrenia: are they still useful?

  2023cites this paper
• Congenital blindness does not protect against a schizophrenia-related phenotype in rodents.

  2023cites this paper
• Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High-Risk for Psychosis

  2023cites this paper
• Short-term, but not long-term, beneficial effects of concomitant benzodiazepine use on clinical course in patients with schizophrenia

  2022cites this paper
• Use of prepubertal environment enrichment to prevent dopamine dysregulation in a neurodevelopmental rat model of schizophrenia risk

  2022cites this paper
• Adult stress exposure blunts dopamine system hyperresponsivity in a neurodevelopmental rodent model of schizophrenia

  2022cites this paper
• Efeitos do levetiracetam sobre as alterações comportamentais e eletrofisiológicas tipo-esquizofrenia induzidas pela exposição ao estresse na adolescência

  2022cites this paper
• Hippocampal circuit dysfunction in psychosis

  2022cites this paper
• Using animal models for the studies of schizophrenia and depression: The value of translational models for treatment and prevention

  2022cites this paper
• What Can We Learn from Animal Models to Study Schizophrenia?

  2022cites this paper
• Advantages and Limitations of Animal Schizophrenia Models

  2022cites this paper
• Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models

  2022cites this paper
• Gestational methylazoxymethanol acetate administration alters α5GABAA and NMDA receptor density: An integrated neuroimaging, behavioral and pharmacological study

  2021influential citation
• Prenatal MAM treatment altered fear conditioning following social isolation: relevance to schizophrenia.

  2021cites this paper
• The MAM-E17 neurodevelopmental model of schizophrenia

  2021cites this paper
• GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia

  2021cites this paper
• Animal Models of Relevance to the Schizophrenia Prodrome

  2021cites this paper
• Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia.

  2021cites this paper
• Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

  2021cites this paper
• Reduced cortical GABA and glutamate in high schizotypy

  2021cites this paper
• The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus

  2020cites this paper
• Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.

  2020cites this paper
• Prepubertal Environmental Enrichment Prevents Dopamine Dysregulation and Hippocampal Hyperactivity in MAM Schizophrenia Model Rats.

  2020influential citation
• Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development.

  2020cites this paper
• Are CB2 Receptors a New Target for Schizophrenia Treatment?

  2020cites this paper
• Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies.

  2020cites this paper
• Neurochemical models of psychosis risk and onset

  2020cites this paper
• Spirituality, religion, and psychotic disorders

  2020cites this paper
• Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia

  2020cites this paper
• Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis

  2020cites this paper
• Adolescent Neurodevelopment and Vulnerability to Psychosis.

  2020cites this paper
• Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure.

  2019cites this paper
• Behavioural abnormalities and novel pharmaceutical intervention in acute and developmental rat models of psychiatric illness

  2019cites this paper
• Elevated glutamate, glutamine and GABA levels and reduced taurine level in a schizophrenia model using an in vitro proton nuclear magnetic resonance method.

  2019cites this paper
• The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.

  2019cites this paper
• Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis

  2019cites this paper
• A Network Analysis of Epigenetic and Transcriptional Regulation in a Neurodevelopmental Rat Model of Schizophrenia With Implications for Translational Research.

  2019cites this paper
• Stress during critical periods of development and risk for schizophrenia.

  2019cites this paper
• Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice

  2019cites this paper
• Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

  2019cites this paper
• Maternal Immune Activation during Pregnancy Alters the Behavior Profile of Female Offspring of Sprague Dawley Rats

  2019cites this paper
• Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats

  2019cites this paper
• The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis.

  2019cites this paper
• Stress Exposure in Dopamine D4 Receptor Knockout Mice Induces Schizophrenia-Like Behaviors via Disruption of GABAergic Transmission.

  2018cites this paper
• University of Birmingham Cortical GABA in Subjects at Ultra-High Risk of Psychosis

  2018cites this paper
• State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia

  2018cites this paper
• Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia

  2018cites this paper
• Prospective Analysis of the Effects of Maternal Immune Activation on Rat Cytokines during Pregnancy and Behavior of the Male Offspring Relevant to Schizophrenia

  2018cites this paper
• Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis

  2018cites this paper
• Hyperactive behavior in female rats in utero‐exposed to group B Streptococcus‐induced inflammation

  2018cites this paper
• Juvenile treatment with mGluR2/3 agonist prevents schizophrenia‐like phenotypes in adult by acting through GSK3&bgr;

  2018cites this paper
• Effects of environmental enrichment on the activity of the amygdala in micrencephalic rats exposed to a novel open field

  2018cites this paper
• University of Birmingham Cortical GABA in Subjects at Ultra-High Risk of Psychosis

  2018cites this paper
• Dopamine System Dysregulation and the Pathophysiology of Schizophrenia: Insights From the Methylazoxymethanol Acetate Model.

  2017cites this paper
• Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms

  2017cites this paper
• Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.

  2017cites this paper
• Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.

  2017cites this paper
• The methylazoxymethanol acetate rat model: molecular and epigenetic effect in the developing prefrontal cortex

  2017cites this paper
• Adolescent Stress as a Driving Factor for Schizophrenia Development-A Basic Science Perspective.

  2017cites this paper
• Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats

  2017cites this paper
• Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study

  2017cites this paper
• The MAM‐E17 schizophrenia rat model: Comprehensive behavioral analysis of pre‐pubertal, pubertal and adult rats

  2017cites this paper
• Schizophrenia - an anxiety disorder?

  2017cites this paper
• Towards an Integrated View of Early Molecular Changes Underlying Vulnerability to Social Stress in Psychosis.

  2017cites this paper
• Attention regulation and behavioural flexibility in rats with relevance to schizophrenia

  2017cites this paper
• Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model.

  2016influential citation
• Maternal Immune Activation Disrupts Dopamine System in the Offspring

  2016cites this paper
• Altering the course of schizophrenia: progress and perspectives

  2016cites this paper
• Developmental timing and critical windows for the treatment of psychiatric disorders

  2016cites this paper
• Dysregulation of Dopamine Systems in a Developmental Disruption Model of Schizophrenia: Implications for Pathophysiology, Treatment, and Prevention

  2016cites this paper
• Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration

  2016cites this paper
• Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam

  2016cites this paper
• Prefrontal Cortex Dysfunction Increases Susceptibility to Schizophrenia-Like Changes Induced by Adolescent Stress Exposure

  2016cites this paper
• Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression

  2016cites this paper
• Hypofrontality and Posterior Hyperactivity in Early Schizophrenia : Imaging and Behavior in a Preclinical ModelImaging and Behavioral Markers of Early Schizophrenia

  2016cites this paper
• Maternal immune activation disrupts dopamine system in the offspring. Category: Research article Short title: Maternal immune activation and dopamine system.

  2016cites this paper
• Neurogenesis and sensorimotor gating: bridging a microphenotype and an endophenotype.

  2015cites this paper
• Dopamine system dysregulation and the pathophysiology of schizophrenia : Insights from the MAM model

  2015cites this paper
• Alterations in spatial memory and anxiety in the MAM E17 rat model of hippocampal pathology in schizophrenia

  2015cites this paper
• Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.

  2015cites this paper
• Effects of Pubertal Cannabinoid Administration on Attentional Set-Shifting and Dopaminergic Hyper-Responsivity in a Developmental Disruption Model of Schizophrenia

  2015cites this paper
• Translating the MAM model of psychosis to humans.

  2015cites this paper
• Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities.

  2015cites this paper
• Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model.

  2014cites this paper
• Protracted maturation of forebrain afferent connections of the ventral tegmental area in the rat

  2014cites this paper